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Abstract 
Authors present the interim analysis of open, prospective, randomized study, comparing the strategy of early (48–72 
hours) and standard (after 72 hours) discharge in low risk patients after myocardial infarction with ST-segment 
elevation (STEMI), treated with successful primary percutaneous coronary intervention (PCI). 
91 patients (22.5% of all STEMI patients admitted  within the period between October 15, 2013 and October 6, 2015), 
who fulfilled given inclusion criteria of low risk,  were randomly assigned to two groups in a 1:1 ratio.  
The primary end point was the composite of death, myocardial infarction (MI), unstable angina, stroke, unplanned 
rehospitalization, repeated target vessel revascularization, stent thrombosis within 90-day follow-up. 
The length of stay was significantly shorter in the intervention group (63.0 ± 7.8 h vs. 91.1 ± 11.9 h, p < 0.0001).  
The primary end point at 3 months occurred in 3 patients assigned to intervention group as compared to 2 patients 
assigned to control group (6.4% vs. 4.5%, p = 1.0 for non-inferiority). There were no significant differences in the 
incidence rates of individual components of the primary end point at 90 days. 
Presented interim data of the study support the claim that early discharge (48–72 hours) in selected patients after 
STEMI, treated with successful primary PCI, is possible and safe, with the results comparable to the later discharge, 
realized in compliance with current guidelines and present everyday clinical practice. 
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/ŶƚƌŽĚƵĐƚŝŽŶ  
 
The length of hospital stay in patients with diagnosis 
of myocardial infarction with ST-segment elevation, 
has been shortened substantially within past 50 years 
[1]. Reduction of health cost associated with this 
strategy was proven also [2–4]. 
The current Guidelines of European Society of 
Cardiology, released in 2012, state, that in the selected 
patients after myocardial infarction with ST-segment 
elevation, the early discharge (after approximately 72 
h) may be considered (class of recommendation IIb, 
level of evidence B), if adequate follow-up is arranged 
[5]. The data reflecting such an approach in clinical 
practice are limited. 
Our first experience with the strategy of length of 
hospital stay shorter than current guidelines recom-
mend, was described previously [6]. 
The aim of this study is to prove that early discharge 
(within 72 hours) in patients with low risk of follow-up 
complications after STEMI, treated with primary PCI, 
is feasible and safe, and that early discharge is "non-
inferior" in comparison with the group of patients 
discharged in a standard way, accordingly with present, 
local practice and physician´s decision (usually 4th - 7th 
day), thus it is not associated with higher incidence of 
complications in the 90th day after myocardial 
infarction. (ClinicalTrials.gov – identifier 
NCT02023983). 
 
 
Methods 
 
This is the interim analysis of prospectively designed, 
open, randomized, monocentric study of patients with 
STEMI, treated with successful primary PCI.  
Inclusion criteria, defining the eligibility of subjects 
for enrollment to the study, are listed in Table 1, plan 
of the study is shown in the Figure 1. Patients with 
comorbidities, requiring additional evaluation within 
primary hospitalization, were excluded. The par-
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ticipants were randomly assigned to two groups in 
a 1:1 ratio. 
The primary end point is the composite of death, 
myocardial infarction, unstable angina, stroke, unplan-
ned rehospitalization, repeated target vessel revas-
cularization and stent thrombosis within 90-day follow-
up.  
No patient was transported back to referring hospital; 
the stress test before discharge was not routinely 
performed. Clinical control of patients, randomized to 
intervention group, was performed in outpatient clinic 
no later than 4 days after discharge. All patients, 
involved in analysis, completed 90-day follow-up. 
 
Tab. 1: Inclusion criteria. 
 
x STEMI treated with successful primary PCI within 12 h of the symptom onset (TIMI flow 3 in infarct-
related artery)  
x ŐĞчϳϱǇĞĂƌƐ 
x >ĞĨƚǀĞŶƚƌŝĐƵůĂƌĞũĞĐƚŝŽŶĨƌĂĐƚŝŽŶшϰϱй 
x One- or two-vessel disease   
x No symptoms of residual ischaemia   
x Haemodynamical and rhythmical stability   
x Absence of comorbidities, requiring continuation of hospitalization 
x Absence of contraindication for dual antiplatelet treatment or need for anticoagulation 
x Supposed cooperation, adherence to medical measures and social background  
TIMI - thrombolysis in myocardial infarction. 
 
 
Fig. 1: Plan of the study.                                                
 
STEMI 
^ƵĐĐĞƐƐĨƵůƉƌŝŵĂƌǇW/ 
ZĂŶĚŽŵŝǌĂƚŝŽŶŝŶĂϭ͗ϭƌĂƚŝŽ 
(24–ϳϮŚŽƵƌƐͿ 
^ƚĂŶĚĂƌĚĚŝƐĐŚĂƌŐĞ 
;ĂĨƚĞƌϳϮŚŽƵƌƐͿ 
ĂƌůǇĚŝƐĐŚĂƌŐĞ 
(48–ϳϮŚŽƵƌƐͿ 
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KƵƚƉĂƚŝĞŶƚĐĂƌĞĂĐĐŽƌĚŝŶŐůǇ 
ƚŽƚŚĞĐƵƌƌĞŶƚůŽĐĂůƉƌĂĐƚŝĐĞ 
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Tab. 2: Baseline clinical characteristics of the analyzed cohorts. 
 
 ĂƌůǇĚŝƐĐŚĂƌŐĞ 
;ǁŝƚŚŝŶϳϮŚŽƵƌƐͿ 
^ƚĂŶĚĂƌĚĚŝƐĐŚĂƌŐĞ Ɖ 
n ϰϳ 44  
Female ϭϮ;Ϯϱ͘ϱйͿ ϵ;ϮϬ͘ϱйͿ 0.625 
Age 56.5 ± 9.5 ϱϳ͘ϵцϴ͘ϳ 0.464 
Hypertension 23 ;ϰϴ͘ϵйͿ Ϯϰ;ϱϰ͘ϱйͿ Ϭ͘ϲϳϲ 
Diabetes ϳ;ϭϰ͘ϵйͿ ϵ;ϮϬ͘ϱйͿ Ϭ͘ϱϴϲ 
Hyperliporoteinemia ϯϬ;ϲϯ͘ϴйͿ ϯϭ;ϳϬ͘ϱйͿ 0.514 
Previous MI Ϯ;ϰ͘ϯйͿ ϭ;Ϯ͘ϯйͿ 1 
Previous PCI ϭ;Ϯ͘ϱйͿ Ϯ;ϰ͘ϱйͿ Ϭ͘ϲϬϴ 
Previous stroke / TIA Ϯ;ϰ͘ϯйͿ ϭ;Ϯ͘ϯйͿ 1 
Peripheral arterial disease 2 ;ϰ͘ϯйͿ ϭ;Ϯ͘ϯйͿ 1 
Smoking ϯϮ;ϲϴ͘ϭйͿ Ϯϵ;ϲϱ͘ϵйͿ 0.325 
Body-mass index 30.6 Ϯϳ͘ϯ 0.0005 
Localization of MI - anterior ϭϭ;Ϯϯ͘ϰйͿ ϭϯ;Ϯϵ͘ϱйͿ  
0.104                  - inferior Ϯϵ;ϲϭ͘ϳйͿ ϯϬ;ϲϴ͘ϮйͿ 
                                 - lateral ϳ;ϭϰ͘ϵйͿ 1 ;Ϯ͘ϯйͿ 
1-vessel disease ϯϬ;ϲϯ͘ϴйͿ Ϯϱ;ϱϲ͘ϴйͿ 0.526 
2-vessel disease ϭϳ;ϯϲ͘ϮйͿ ϭϵ;ϰϯ͘ϮйͿ 
Radial approach ϰϲ;ϵϳ͘ϵйͿ ϰϰ;ϭϬϬйͿ 1 
Drug eluting stent ϯϲ;ϳϲ͘ϲйͿ ϯϵ;ϴϴ͘ϲйͿ Ϭ͘ϭϳϮ 
Initial TIMI flow 0  ϮϮ;ϰϲ͘ϴйͿ ϭϴ;ϰϬ͘ϵйͿ  
Ϭ͘ϳϵϵ                              1   ϱ;ϭϬ͘ϲйͿ ϳ;ϭϲ͘ϵйͿ 
                             2 ϳ;ϭϰ͘ϵйͿ ϱ;ϭϭ͘ϰйͿ 
                             3 ϭϯ;Ϯϳ͘ϳйͿ ϭϰ;ϯϭ͘ϴйͿ 
GP IIbIIIa inhibitors ϴ;ϭϳйͿ Ϯ;ϰ͘ϱйͿ 0.092 
Aspiration thrombectomy Ϯϯ;ϰϴ͘ϵйͿ ϭϴ;ϰϬ͘ϵйͿ 0.529 
>ĞĨƚǀĞŶƚƌŝĐƵůĂƌ&;йͿ 54.4 ± 5.1 54.6 ± 5.3 Ϭ͘ϳϳϴ 
 
TIA – transient ischemic attack, GP IIbIIIa inhibitors - glycoprotein IIbIIIa inhibitors,  
EF – ejection fraction 
 
^ƚĂƚŝƐƚŝĐĂůĂŶĂůǇƐŝƐ  
 
Statistical analysis was performed with SPSS 
Statistics software package, version 22 (IBM 
Corporation, Armonk, NY, USA). For comparison 
of qualitative variables between two groups 
Fischer’s exact test was used. For comparison of 
quantitative variables we used Student’s t-test (age, 
BMI), respectively Mann-Whitney U test (length of 
stay, left ventricular ejection fraction). Normality of 
data was assessed with Shapiro-Wilk test. Values of 
p < 0.05 were considered as statistically significant. 
 
ZĞƐƵůƚƐ  
 
409 consecutive patients with diagnosis of 
STEMI, treated with primary PCI, were admitted to 
our center within the period between October 15, 
2013 and October 6, 2015.  
91 (22.5%) of them fulfilled inclusion criteria, were 
recruited for study and randomized to two groups. 
Their baseline characteristics are shown in Table 2, 
except body-mass index the both cohorts were 
similar.  
Inferior localization of MI clearly dominated. 
Radial approach as well as the use of drug eluting 
stents were preferred, aspiration thrombectomy was 
used in less than half of cases, glycoprotein IIbIIIa 
inhibitors were administrated in 17% and 4.5% 
respectively. 
The length of stay was significantly (p < 0.0001) 
shorter in the intervention group (Tab. 3, Fig 2).  
The primary end point at 3 months occurred in 
3 patients assigned to intervention group as com-
pared to 2 patients assigned to control group (6.4% 
vs. 4.5%, p = 1.0 for non-inferiority). 
There were no significant differences in the 
incidence rates of individual components of the 
primary end point at 90 days between the group 
with early discharge and control cohort. 
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Neither death nor stroke occurred in either group 
in this period. 
 
 
Tab. 3: Length of stay. 
 
 ĂƌůǇĚŝƐĐŚĂƌŐĞ ^ƚĂŶĚĂƌĚĚŝƐĐŚĂƌŐĞ Ɖ 
Average (h) ϲϯ͘Ϭцϳ͘ϴ 91.1 ± 11.9  
< 0,0001 Median (h) 63.0 92.0 
Minimal (h) 43.0 ϳϰ͘Ϭ 
Maximal (h) ϳϮ͘Ϭ 120.0 
 
 
Fig 2: Quartile box chart – distribution of length of stay in compared groups. 
 
 
 
 
Tab. 4: Results. 
 
  
  
EĂƌůǇĚŝƐĐŚĂƌŐĞ ^ƚĂŶĚĂƌĚĚŝƐĐŚĂƌŐĞ Ɖ 
Ŷ % Ŷ % 
Primary composite endpoint 3 ϲ͘ϰй 2 ϰ͘ϱй 1 
Death 0 Ϭй 0 Ϭй  - 
Myocardial infarction 1 Ϯ͘ϭй 1 Ϯ͘ϯй 1 
Unstable angina  1 Ϯ͘ϭй 0 Ϭй 1 
Unplanned rehospitalization 3 ϲ͘ϰй 2 ϰ͘ϱй 1 
Repeated target vessel 
revascularization 
1 Ϯ͘ϭй 1 Ϯ͘ϯй 1 
Stent thrombosis 0 Ϭй 1 Ϯ͘ϯй 1 
Stroke 0 Ϭй 0 Ϭй  - 
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ŝƐĐƵƐƐŝŽŶ  
 
Numerous references to the issue of early 
discharge after STEMI are available, but their 
overview indicates that methodology of these works 
widely varies (3–63% of probands fulfilled criteria 
for early discharge!).  
At present, the low risk STEMI population is 
relatively well defined [7–11]. Several risk scores 
were created to identify the patients with low risk 
of subsequent complications [9–11]. De Luca et al. 
in their study developed practical score (Zwolle 
Risk Score for STEMI) for risk stratification in low 
risk patients with STEMI, treated with primary PCI 
[9]. Age, anterior infarction, Killip class, ischemic 
time, postprocedural TIMI flow in infarct-related 
artery and multi-vessel disease were defined as 
independent predictors of 30-day mortality. Score 
 designates low-risk patients. 
Current guidelines for early discharge are based 
just on limited data derived from randomized trials. 
In the small, pilot SAFE-DEPART study, 
Kotowycz et al. randomized 54 low risk patients 
with STEMI (Zwolle score  WUHDWHd with 
primary (or rescue) PCI, to the early discharge (48–
72 h) or discharge at the discretion of treating 
physician (control group) [12]. The primary 
outcomes of this study were to demonstrate 
feasibility and safety of such an approach. In the 
intervention group 74% of patients were discharged 
within 72 h, length of stay in hospital was short in 
all study patients (median 55 h). No death occurred 
in either group and no significant difference in the 
rate of rehospitalization between both groups was 
observed. There were no significant differences in 
compliance, quality of life or smoking cessation. 
Noman et al. in retrospective analysis collected 
data of 2448 STEMI patients treated with primary 
PCI and surviving to hospital discharge [13]. 
Patients with TIMI 3 flow in infarct-related artery 
and without haemodynamic or arrhythmic comp-
lications were considered for early discharge at the 
discretion of the attending physician: a total of 1542 
patients (63%) were discharged within 2 days of 
admission (early discharge group) and remaining 
37% after 2 days (late discharge). The 30-day post-
discharge mortality rate was 0.71% in the early 
group and 1.66% in the late group. During a mean 
follow-up of 584 days, mortality was 4.3% and 
12.3% respectively. The authors conclude that in 
unselected cohort of consecutive ‘‘real-world’’ 
STEMI patients those with low risk of subsequent 
complications (almost two thirds!) can be safely 
discharged within 2 days following primary PCI. 
Recently, Azzalini et al. in EDAMI trial [14] in 
the cohort of 100 low-ULVN =ZROOH ULVN VFRUH
patients with STEMI compared the group with 
HDUO\ GLVFKDUJH KRXUV DQG WKH JURXSZLWK D
conventional discharge strategy. The primary end 
point was defined as following: the feasibility of the 
early discharge strategy (EDS) RI('6
SDWLHQWV GLVFKDUJHG   K    YLVLWHG E\
a QXUVHGD\VDIWHUGLVFKDUJHZLWK
YLVLWV E\ WKH QXUVH DQG    YLVLWHG E\
a FDUGLRORJLVW   PRQWKV /HQJWK RI VWD\ ZDV
shorter in early discharge strategy (70.1 vs. 111.8 h, 
p < 0.001). Early discharge feasibility was: (1) 
72.2%; (2) 81.5%; (3) 76.9%; (4) 72.2%. No 
adverse events or differences in intervention goals 
and quality of life were registered between groups.  
Our interim analysis indicates, that early dis-
charge after STEMI, treated with primary PCI is 
feasible and safe, without higher risk of subsequent 
complications. It is fair to add, that the shorter 
hospital stay is associated with limited time for 
proper patient rehabilitation, education or titration 
of medication. It is therefore entirely appropriate to 
carry out early clinical post-discharge control and 
arrange subsequent regular care. In accordance with 
Azzalini et al. we consider reasonable the discharge 
not earlier than after 48 hours.   
 
 
ŽŶĐůƵƐŝŽŶƐ  
 
Presented interim data of the monocentric, open, 
randomized study support the claim that early 
discharge (48–72 hours) in selected, low risk 
patients after STEMI, treated with successful 
primary PCI, is possible and safe, with the results 
comparable to the later discharge, realized in 
compliance with current guidelines and present 
everyday clinical practice. According to this 
analysis, this strategy applies to at least 22.5% of 
all STEMI patients. Final results of the trial will be 
available in 2017. 
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